Dr. Woodcock, Orphan Drugs and Congressional Reform – Be Careful What You Ask For
This article was originally published in RPM Report
FDA’s top drug review official is wary of calls for legislative changes affecting the approval standard. The co-founder of the Abigail Alliance, Steven Walker, sees it differently. Here is his response to an article published by The RPM Report about Woodcock’s remarks at the US Rare Diseases Conference.